Shorter Disease Duration Predicts Earlier Complete Skin Clearance in Biologic-naïve Psoriasis Treated with Biologics
The association between psoriasis disease duration and complete skin clearance after biologic initiation remains uncertain. This single-centre retrospective study included 218 biologic-naïve patients who initiated biologic therapy between 2010 and 2024. Disease duration was defined as the interval from symptom onset to biologic initiation and categorized as ≤2 years or >2 years. Absolute Psoriasis Area and Severity Index (PASI) 0 was assessed at 3 months, 6 months, 1 year and 2 years using an as-observed approach. Twenty-nine patients (13.3%) had disease duration ≤2 years. At 3 months, absolute PASI 0 was achieved in 6/29 (20.7%) patients with shorter disease duration and 14/189 (7.4%) with longer disease duration (p=0.033). No significant differences were detected at subsequent assessments. In an exploratory multivariable Cox model including baseline PASI, shorter disease duration was associated with early PASI 0 achievement (hazard ratio 4.75; 95% confidence interval 1.57-14.40). Sparse early events and incomplete covariate data limit interpretation. Shorter disease duration was associated with earlier complete skin clearance; larger studies are needed to establish whether this association is independent of treatment selection and other confounders.
Authors
- Masahiro Kamata (ORCID: https://orcid.org/0000-0003-0976-4982)
- Itsumi Mizukawa
- Azusa Hiura
- Ryosuke Takeshima
- Ayu Watanabe
- Kotaro Hayashi (ORCID: https://orcid.org/0000-0002-0134-2913)
- Shoya Suzuki
- Chika Chijiwa
- Yoshiki Okada
- Yoshitsugu KUBO
Institutions
- Teikyo University (JP)
Publication Details
- Journal
- Acta Dermato Venereologica
- Published
- 2026-11-18
- DOI
- https://doi.org/10.2340/actadv.v106.adv-2026-0697
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00